Shaun Smart, MD
Clinical Neurophysiology · Houston, TXNPI 1942497870
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,730 of the $8,864 with a category attached, or 64.6%. UCB, Inc. accounts for 82.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $5,156 and has fallen 92.3% since, to $395 in 2025.
Across 37 payments — averaging $239.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$7K
- Neurelis, Inc.$301
- Johnson & Johnson$238
- Teva Pharmaceuticals USA, Inc.$232
- Neuropace, Inc.$115
- Novo Nordisk$114
- plus $515 from 8 others
What the payments were for
- Consulting fees$5,73065%
- Travel & lodging$99411%
- Food & beverage$2,14024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 15 | $7,349 |
| Neurelis, Inc. | 3 | $301 |
| Johnson & Johnson | 2 | $238 |
| Teva Pharmaceuticals USA, Inc. | 2 | $232 |
| Neuropace, Inc. | 1 | $115 |
| Novo Nordisk | 2 | $114 |
| Janssen Scientific Affairs, LLC | 2 | $111 |
| Neurocrine Biosciences, Inc. | 1 | $109 |
| AstraZeneca | 1 | $100 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $100 |
| Aquestive Therapeutics, Inc. | 3 | $36 |
| Greenwich Biosciences, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$245
- XARELTO$238
- Briviact$150
- Austedo XR$125
- RNS Neurostimulator Kit$115
- Fintepla$113
- AUSTEDO$107
- ULTOMIRIS$100
How this compares
$8,864 in reported general payments places this provider in the 75th percentile of 50 clinical neurophysiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical neurophysiology in Houston
- Thy NguyenHouston$133K
- Nora Vanegas ArroyaveHouston$82K
- Samden LhatooHouston$66K
- Omotola HopeHouston$63K
- Hina DaveHouston$48K
- Monika UmmatHouston$36K
- Sudha TallavajhulaHouston$14K
- Victor LevinHouston$10K
- Kristin BrownHouston$5K
- Jay GavvalaHouston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.